Triose phosphate isomerase from the blood fluke <em>Schistosoma mansoni</em>:Biochemical characterisation of a potential drug and vaccine target
Data(s) |
23/09/2013
|
---|---|
Resumo |
The glycolytic enzyme triose phosphate isomerase from Schistosoma mansoni is a potential target for drugs and vaccines. Molecular modelling of the enzyme predicted that a Ser-Ala-Asp motif which is believed to be a helminth-specific epitope is exposed. The enzyme is dimeric (as judged by gel filtration and cross-linking), resistant to proteolysis and highly stable to thermal denaturation (melting temperature of 82.0°C). The steady-state kinetic parameters are high (Km for dihydroxyacetone phosphate is 0.51mM; Km for glyceraldehyde 3-phosphate is 1.1mM; kcat for dihydroxyacetone phosphate is 7800s(-1) and kcat for glyceraldehyde 3-phosphate is 6.9s(-1)). |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Zinsser , V L , Farnell , E , Dunne , D W & Timson , D J 2013 , ' Triose phosphate isomerase from the blood fluke Schistosoma mansoni : Biochemical characterisation of a potential drug and vaccine target ' FEBS Letters , pp. 3422–3427 . DOI: 10.1016/j.febslet.2013.09.022 |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300 #Biochemistry, Genetics and Molecular Biology(all) #/dk/atira/pure/subjectarea/asjc/2400 #Immunology and Microbiology(all) |
Tipo |
article |